Mole Removal / Naevus Excision | Mole Removal in Special Situations

Local anaesthetics can cross the placenta, so pregnancy changes the risk balance. Lidocaine, etidocaine and prilocaine are category B, while bupivacaine and mepivacaine are category C because of possible fetal bradycardia. Studies show first-trimester lidocaine safety without adverse maternal or teratogenic effects. Pregnancy affects epidural and spinal anaesthesia more than infiltration or topical anaesthesia, which dermatologists more commonly use. For mole removal, the method depends on the mole’s type, size, location and depth, and active infection or uncontrolled diabetes may delay treatment. There are no absolute contraindications for mole techniques, though radiofrequency is not suitable with cardiac disease, pacemakers or metallic prostheses, and shave or punch excision is not done when cancer is suspected.

Pregnancy can increase circulating MSH and sex hormones, so pre-existing moles may darken; dermoscopic appearance may also change, and some changes may reverse after delivery. Melanoma is among the common malignancies during pregnancy, and pregnant women may present with thicker melanoma, possibly because of delayed diagnosis. However, prognosis does not differ from nonpregnant patients when matched for stage and thickness. Surgical management follows the same guidelines as for nonpregnant patients. Therefore, a suspicious pigmented lesion during pregnancy should be assessed promptly, and early biopsy may be recommended. A change in size, shape, colour or border can be a warning sign, and not every change means cancer.

Method depends on mole type, size, location and anticipated depth. An acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma formation. Minimal damage to surrounding normal skin and an aesthetically acceptable scar are goals. Suspicion of dysplastic change warrants excision biopsy with histopathological assessment. Blood investigations are done to rule out diabetes mellitus and bleeding disorders. There are no absolute contraindications for any of the techniques for mole surgery; procedure is deferred for active infection or uncontrolled diabetes. Radiofrequency is contraindicated with cardiac disease, pacemakers or metallic prosthesis; shave excision and punch techniques are contraindicated in suspected malignancy.

For dermatologic surgery, routinely stopping medically necessary blood thinners may carry greater risk than continuing them, especially in Mohs surgery, so patients should be counselled. In mole surgery, no technique has absolute contraindications, but bleeding diathesis is listed as a contraindication, and blood tests may rule out bleeding disorders. The method depends on type, size, location and depth; an acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma formation. In one oculoplastic report, patients continuing anticoagulants had no intraoperative complications and one postoperative bleeding complication among 145 patients, though controversy remains. It is prudent to check with your medical doctor whether blood thinners can be stopped before and after the procedure.

The source lists bleeding diathesis among contraindications for mole removal, while also noting that blood investigations are done to rule out diabetes mellitus and bleeding disorders. The method depends on the mole’s type, size, location and anticipated depth, and an acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma formation. Because bleeding control matters, your individual assessment is important, and the team may inspect the wound for discharge, hematoma or dehiscence after surgery. Complications are uncommon if surgical principles are followed, but early complications can include hematoma, wound margin necrosis, wound dehiscence and secondary infection. Late complications can include depression, hyperpigmentation, dog ears and atrophic scars.

The source notes no absolute contraindications for mole removal techniques, while active infection or uncontrolled diabetes may lead to deferral. Blood tests may check for diabetes and bleeding disorders. Radiofrequency is avoided with certain heart conditions, a pacemaker or metal implants, and shave or punch methods are avoided if cancer is suspected. Late complications are often linked to patient factors such as keloidal tendency, sun exposure, darker skin types and a genetic background of poor wound healing, so careful patient selection matters. The method depends on the mole’s type, size, location and anticipated depth, and the goal is complete removal with minimal surrounding damage and an acceptable scar.

Mole is a benign cluster of pigment cells; removal aims to remove it completely while limiting damage to nearby skin and achieving an acceptable scar. The method depends on type, size, location and depth. Keloids are raised scars that often recur, and keloidal tendency is a late-complication risk. Preventive measures should be considered for patients with keloidal tendency when elective procedures are planned, and they should be cautioned about future elective procedures. Late complications can relate to keloidal tendency, sun exposure, darker skin types and poor wound healing, so patient selection matters. An acquired melanocytic nevus should be removed in toto to reduce recurrence and pseudomelanoma formation. Suspicion of dysplastic change warrants excision biopsy and histopathological assessment.

The listed contraindications are active infection, keloidal tendency, bleeding problems and uncontrolled diabetes, not tanning. The method depends on the mole’s type, size, location and depth. Late complications are more likely with excessive sun exposure and darker skin tones (Fitzpatrick types 4–5), so sun protection matters. A mole that has recently changed in size, colour or symptoms should be assessed before removal, because suspicion of dysplastic change may warrant excision biopsy and pathology review. The aim is to remove the mole completely while limiting damage to surrounding skin and achieving an acceptable scar. Your doctor can discuss these trade-offs with you. Sun protection is especially important after treatment.

UV light from the sun can increase the chance of a mole becoming cancerous, so regular checks and sun protection matter. Removal method depends on the mole’s type, size, location and depth; an acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma formation. Surgery is usually deferred for active infection or uncontrolled diabetes; bleeding or keloidal tendency also matter. Suspected dysplastic change warrants excision biopsy with histopathological assessment. Complications are uncommon when principles are followed, but late problems can relate to keloidal tendency, excessive sun, darker skin types and poor wound healing. Healed sun-exposed areas may need sunscreen for one to two months after healing.

The source lists active infection among contraindications for mole removal and says the procedure is deferred when infection is present at the site. Blood tests may be used to rule out diabetes and bleeding disorders. The chosen method depends on the mole’s type, size, location and anticipated depth, and an acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma formation. If malignancy is suspected, excision biopsy with histopathological assessment is warranted. Because most mole removal is for aesthetic reasons, timing can be adjusted rather than forcing surgery through an active infection. Uncontrolled diabetes is also a reason to defer. Bleeding disorders may need evaluation.

Moles are benign clusters of pigment cells; removal is often requested for appearance, irritation or concern about change. The method depends on the mole’s type, size, location and depth, and the whole mole is usually removed to reduce recurrence and pseudomelanoma formation. Active infection, uncontrolled diabetes, bleeding tendency or keloid tendency are reasons to defer or avoid certain approaches. Acne itself is not listed as a contraindication, but inflamed acne near the site may matter because infection control and healing come first. Suspicion of cancerous change needs specialist assessment rather than cosmetic removal. The aim is an acceptable scar with minimal damage to surrounding skin.

No technique has an absolute contraindication, yet the procedure is usually deferred for active infection or uncontrolled diabetes. Blood tests may check for diabetes and bleeding disorders, and informed consent is obtained. Radiofrequency is unsuitable with heart disease, pacemakers or metal implants; shave excision and punch techniques are unsuitable when cancer is suspected; punch excision with grafting is unsuitable for larger, irregular or mobile-area moles. The method depends on the mole’s type, size, location and depth, and an acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma risk. Dr. Vishal Purohit can review your history during consultation and decide whether treatment should be staged or modified.

Mole removal depends on the lesion's type, size, location and anticipated depth. A mole that has developed over time should be removed completely to reduce recurrence and pseudomelanoma formation. Any suspicion of abnormal change warrants removal with lab testing and histopathological assessment. There are no absolute contraindications for mole techniques, but active infection, keloidal tendency, bleeding problems and uncontrolled diabetes are contraindications. When cancer is suspected, shallow shave or punch removal is avoided. For suspected non-melanoma skin cancer, management depends on biopsy, pathology, surgical tolerance, margins, Mohs appropriateness, reconstruction and follow-up. Dr. Purohit can carefully explain these options during consultation.